Ibutamoren Mesylate
| Title | Journal |
|---|---|
| Overlapping binding site for the endogenous agonist, small-molecule agonists, and ago-allosteric modulators on the ghrelin receptor. | Molecular pharmacology 20090101 |
| Summaries for patients. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults. | Annals of internal medicine 20081104 |
| Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial. | Annals of internal medicine 20081104 |
| (D)-2-tert-Butoxycarbonylamino-5,5-difluoro-5-phenyl-pentanoic acid: synthesis and incorporation into the growth hormone secretagogues. | Bioorganic & medicinal chemistry letters 20080715 |
| Growth hormone and insulin-like growth factor-I as an endocrine axis in Alzheimer's disease. | Endocrine, metabolic & immune disorders drug targets 20080601 |
| Ghrelin receptor (GHS-R1A) agonists show potential as interventive agents during aging. | Annals of the New York Academy of Sciences 20071101 |
| Nonpeptide and peptide growth hormone secretagogues act both as ghrelin receptor agonist and as positive or negative allosteric modulators of ghrelin signaling. | Molecular endocrinology (Baltimore, Md.) 20050901 |
| Development of growth hormone secretagogues. | Endocrine reviews 20050501 |
| Ghrelin and des-acyl ghrelin both inhibit isoproterenol-induced lipolysis in rat adipocytes via a non-type 1a growth hormone secretagogue receptor. | European journal of pharmacology 20040913 |
| [Ghrelin and bone metabolism]. | Nihon rinsho. Japanese journal of clinical medicine 20040901 |
| [Ghrelin-related drugs: clinical perspectives]. | Nihon rinsho. Japanese journal of clinical medicine 20040901 |
| The effects of MK-0677, an oral growth hormone secretagogue, in patients with hip fracture. | Journal of the American Geriatrics Society 20040401 |
| Effect of ghrelin and synthetic growth hormone secretagogues in normal and ischemic rat heart. | Basic research in cardiology 20031101 |
| Pyrazolinone-piperidine dipeptide growth hormone secretagogues (GHSs). Discovery of capromorelin. | Bioorganic & medicinal chemistry 20030220 |
| Highly potent growth hormone secretagogues: hybrids of NN703 and ipamorelin. | Bioorganic & medicinal chemistry letters 20010723 |
| Spiro(indoline-3,4'-piperidine) growth hormone secretagogues as ghrelin mimetics. | Bioorganic & medicinal chemistry letters 20010723 |
| Effects of oral administration of ibutamoren mesylate, a nonpeptide growth hormone secretagogue, on the growth hormone-insulin-like growth factor I axis in growth hormone-deficient children. | Clinical pharmacology and therapeutics 20010701 |
| Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women. | The Journal of clinical endocrinology and metabolism 20010301 |
| Binding of 125I-labeled ghrelin to membranes from human hypothalamus and pituitary gland. | Journal of endocrinological investigation 20010301 |
| Growth hormone secretagogue receptor family members and ligands. | Endocrine 20010201 |
| Molecular analysis of rat pituitary and hypothalamic growth hormone secretagogue receptors. | Molecular endocrinology (Baltimore, Md.) 19970401 |